Market Overview:
The global tinea versicolor treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of tinea versicolor, rising awareness about available treatments, and growing demand for better-tolerated antifungal therapies. The global tinea versicolor treatment market is segmented by type, application, and region. By type, the market is segmented into antifungal shampoos, antifungal creams, drugs, and others. Antifungal shampoos are expected to dominate the market due to their easy availability and low cost as compared to other types of therapies. By application, hospitals are expected to account for the largest share of the global tinea versicolor treatment market due in part to increasing incidence rates of this condition among hospitalized patients worldwide.
Product Definition:
Tinea versicolor is an infection caused by a yeast-like fungus. It most often affects the skin on the back, chest, and neck. The fungus can also cause a rash on the face. Tinea versicolor is common and can occur at any age. Treatment with antifungal medicine usually clears up the infection within a few weeks.
Antifungal Shampoos:
Antifungal shampoos are topical products that contain antifungal agents such as miconazole, clotrimazole, butoconazole or econazole. These products are used for the treatment of tinea Versicolor (UV) Treatment and is one of the most effective treatment available in the market. UV radiation can only kill fungi cells; it does not affect human skin cells.
Antifungal Creams:
Antifungal creams are topical medications used for the treatment of tinea Versicolor. The most common types of ringworm including athlete's foot, jock itch, and ringworm is caused by a fungal infection. Fungi infections may occur anywhere but mostly on the scalp, feet, and hands.
Application Insights:
The others segment held the largest share of the global tinea versicolor treatment market in 2017. This is due to increasing number of patients suffering from diabetes and other skin diseases, such as eczema and psoriasis. Moreover, an increase in travel activities has increased the risk of acquiring fungal infections including tinea versicolor. As a result, antifungal creams are preferred for application on lesions caused by this condition.
Medical research centers accounted for a significant share in 2017 owing to advanced medical facilities available there for diagnosis and treatment options compared with hospitals or dermatology clinics located at regional level hospitals or less-developed townships across countries worldwide.
Regional Analysis:
North America dominated the global tinea versicolor treatment market in 2017. This is due to the presence of a large number of players, high adoption rate for new technologies, and availability of advanced products. Moreover, increasing prevalence of onychomycosis in this region is anticipated to fuel growth during the forecast period. For instance, according to data published by CDC National Center for Health Statistics (NCHS), between 2011 and 2015 around 6 million people were diagnosed with nail fungus each year in U.S.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising disposable income levels coupled with growing awareness about various treatment options available for tinea versicolor infections among patients & physicians alike.
Growth Factors:
- Increasing incidence of tinea versicolor due to changing lifestyle and environmental factors
- Growing awareness about the disease and its treatment among people
- Rising demand for better and more effective therapies for tinea versicolor
- Availability of new, safe, and effective drugs for the treatment of tinea versicolor
- Technological advancements in diagnosis and treatment of the disease
Scope Of The Report
Report Attributes
Report Details
Report Title
Tinea Versicolor Treatment Market Research Report
By Type
Antifungal Shampoos, Antifungal Creams, Drugs, Others
By Application
Hospitals, Dermatology Clinics, Medical Research Centers, Others
By Companies
Novartis, Pfizer, Teva Pharmaceutical, Bayer, Enzon Pharmaceuticals, Galderma, Gilead, Astellas Pharma, Taro Pharmaceutical, Bausch Health
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
178
Number of Tables & Figures
125
Customization Available
Yes, the report can be customized as per your need.
Global Tinea Versicolor Treatment Market Report Segments:
The global Tinea Versicolor Treatment market is segmented on the basis of:
Types
Antifungal Shampoos, Antifungal Creams, Drugs, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Dermatology Clinics, Medical Research Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Pfizer
- Teva Pharmaceutical
- Bayer
- Enzon Pharmaceuticals
- Galderma
- Gilead
- Astellas Pharma
- Taro Pharmaceutical
- Bausch Health
Highlights of The Tinea Versicolor Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antifungal Shampoos
- Antifungal Creams
- Drugs
- Others
- By Application:
- Hospitals
- Dermatology Clinics
- Medical Research Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tinea Versicolor Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Tinea versicolor is a skin infection caused by the fungus Malassezia furfur. Treatment typically includes topical antifungal medications and/or systemic antibiotics. In some cases, laser therapy may be used to treat the underlying skin lesions.
Some of the major players in the tinea versicolor treatment market are Novartis, Pfizer, Teva Pharmaceutical, Bayer, Enzon Pharmaceuticals, Galderma, Gilead, Astellas Pharma, Taro Pharmaceutical, Bausch Health.
The tinea versicolor treatment market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Tinea Versicolor Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Tinea Versicolor Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Tinea Versicolor Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Tinea Versicolor Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Tinea Versicolor Treatment Market Size & Forecast, 2018-2028
4.5.1 Tinea Versicolor Treatment Market Size and Y-o-Y Growth
4.5.2 Tinea Versicolor Treatment Market Absolute $ Opportunity
Chapter 5 Global Tinea Versicolor Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Tinea Versicolor Treatment Market Size Forecast by Type
5.2.1 Antifungal Shampoos
5.2.2 Antifungal Creams
5.2.3 Drugs
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Tinea Versicolor Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Tinea Versicolor Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Dermatology Clinics
6.2.3 Medical Research Centers
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Tinea Versicolor Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Tinea Versicolor Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Tinea Versicolor Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Tinea Versicolor Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Tinea Versicolor Treatment Market Size Forecast by Type
9.6.1 Antifungal Shampoos
9.6.2 Antifungal Creams
9.6.3 Drugs
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Tinea Versicolor Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Dermatology Clinics
9.10.3 Medical Research Centers
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Tinea Versicolor Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Tinea Versicolor Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Tinea Versicolor Treatment Market Size Forecast by Type
10.6.1 Antifungal Shampoos
10.6.2 Antifungal Creams
10.6.3 Drugs
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Tinea Versicolor Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Dermatology Clinics
10.10.3 Medical Research Centers
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Tinea Versicolor Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Tinea Versicolor Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Tinea Versicolor Treatment Market Size Forecast by Type
11.6.1 Antifungal Shampoos
11.6.2 Antifungal Creams
11.6.3 Drugs
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Tinea Versicolor Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Dermatology Clinics
11.10.3 Medical Research Centers
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Tinea Versicolor Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Tinea Versicolor Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Tinea Versicolor Treatment Market Size Forecast by Type
12.6.1 Antifungal Shampoos
12.6.2 Antifungal Creams
12.6.3 Drugs
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Tinea Versicolor Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Dermatology Clinics
12.10.3 Medical Research Centers
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Tinea Versicolor Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Tinea Versicolor Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Tinea Versicolor Treatment Market Size Forecast by Type
13.6.1 Antifungal Shampoos
13.6.2 Antifungal Creams
13.6.3 Drugs
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Tinea Versicolor Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Dermatology Clinics
13.10.3 Medical Research Centers
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Tinea Versicolor Treatment Market: Competitive Dashboard
14.2 Global Tinea Versicolor Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis
14.3.2 Pfizer
14.3.3 Teva Pharmaceutical
14.3.4 Bayer
14.3.5 Enzon Pharmaceuticals
14.3.6 Galderma
14.3.7 Gilead
14.3.8 Astellas Pharma
14.3.9 Taro Pharmaceutical
14.3.10 Bausch Health
